Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4 - PubMed (original) (raw)
Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4
Zhimin Feng et al. J Immunol. 2006.
Abstract
Previously, we showed that human epithelial cell-derived beta-defensins (hBD)-2 and -3 block HIV-1 replication via a direct interaction with virions and through modulation of the CXCR4 coreceptor on immunocompetent cells. In the present study, we show that hBD-3 promotes directly the internalization of CXCR4 yet does not induce calcium flux, ERK (ERK-1/2) phosphorylation, or chemotaxis. hBD-3 competes with stromal-derived factor 1 (SDF-1), the natural ligand for CXCR4, for cellular binding and blocks SDF-1-induced calcium flux, ERK-1/2 phosphorylation, and chemotaxis, without effects on other G protein-coupled receptors. The novel activity of this endogenous CXCR4 antagonist may provide a new strategy for HIV therapies or immunomodulation. Moreover, since the SDF-1/CXCR4 axis plays an important role in hemopoiesis, neurogenesis, cardiogenesis, and angiogenesis, endogenous agents such as hBD-3 or its derivatives offer a new paradigm in immunoregulatory therapeutics and provide the opportunity to enhance future drug design.
Similar articles
- Human β-defensin-3 structure motifs that are important in CXCR4 antagonism.
Feng Z, Dubyak GR, Jia X, Lubkowski JT, Weinberg A. Feng Z, et al. FEBS J. 2013 Jul;280(14):3365-75. doi: 10.1111/febs.12328. Epub 2013 Jun 7. FEBS J. 2013. PMID: 23659571 Free PMC article. - Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S, Princen K, Liekens S, Vermeire K, De Clercq E, Schols D. Hatse S, et al. Cytometry A. 2004 Oct;61(2):178-88. doi: 10.1002/cyto.a.20070. Cytometry A. 2004. PMID: 15382150 - CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes.
Balabanian K, Harriague J, Décrion C, Lagane B, Shorte S, Baleux F, Virelizier JL, Arenzana-Seisdedos F, Chakrabarti LA. Balabanian K, et al. J Immunol. 2004 Dec 15;173(12):7150-60. doi: 10.4049/jimmunol.173.12.7150. J Immunol. 2004. PMID: 15585836 - Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication.
Quiñones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, Marotta ML, Mirza M, Jiang B, Kiser P, Medvik K, Sieg SF, Weinberg A. Quiñones-Mateu ME, et al. AIDS. 2003 Nov 7;17(16):F39-48. doi: 10.1097/00002030-200311070-00001. AIDS. 2003. PMID: 14571200 - LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
Wu M, Chen Q, Li D, Li X, Li X, Huang C, Tang Y, Zhou Y, Wang D, Tang K, Cao L, Shen S, Li G. Wu M, et al. J Cell Biochem. 2008 Jan 1;103(1):245-55. doi: 10.1002/jcb.21400. J Cell Biochem. 2008. PMID: 17549698
Cited by
- Interaction and dynamics of chemokine receptor CXCR4 binding with CXCL12 and hBD-3.
Penfield J, Zhang L. Penfield J, et al. Commun Chem. 2024 Sep 13;7(1):205. doi: 10.1038/s42004-024-01280-6. Commun Chem. 2024. PMID: 39271963 Free PMC article. - Understanding the Role of Antimicrobial Peptides in Neutrophil Extracellular Traps Promoting Autoimmune Disorders.
Biswas S, Sarojini S, Jayaram S, Philip I, Umesh M, Mascarenhas R, Pappuswamy M, Balasubramanian B, Arokiyaraj S. Biswas S, et al. Life (Basel). 2023 Jun 1;13(6):1307. doi: 10.3390/life13061307. Life (Basel). 2023. PMID: 37374090 Free PMC article. Review. - The initial interplay between HIV and mucosal innate immunity.
Caputo V, Libera M, Sisti S, Giuliani B, Diotti RA, Criscuolo E. Caputo V, et al. Front Immunol. 2023 Jan 30;14:1104423. doi: 10.3389/fimmu.2023.1104423. eCollection 2023. Front Immunol. 2023. PMID: 36798134 Free PMC article. Review. - Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands.
Zhou Z, Staropoli I, Brelot A, Suzanne P, Lesnard A, Fontaine F, Perato S, Rault S, Helynck O, Arenzana-Seisdedos F, Sopkova-de Oliveira Santos J, Lagane B, Munier-Lehmann H, Colin P. Zhou Z, et al. Molecules. 2023 Jan 24;28(3):1156. doi: 10.3390/molecules28031156. Molecules. 2023. PMID: 36770826 Free PMC article. - Improving Fmoc Solid Phase Synthesis of Human Beta Defensin 3.
Walewska A, Kosikowska-Adamus P, Tomczykowska M, Jaroszewski B, Prahl A, Bulaj G. Walewska A, et al. Int J Mol Sci. 2022 Oct 19;23(20):12562. doi: 10.3390/ijms232012562. Int J Mol Sci. 2022. PMID: 36293413 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AI 36219/AI/NIAID NIH HHS/United States
- AI 51649/AI/NIAID NIH HHS/United States
- P30 CA 43703/CA/NCI NIH HHS/United States
- R01 DE 015510/DE/NIDCR NIH HHS/United States
- R01 GM 36387/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous